A detailed history of Virginia Retirement Systems Et Al transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 32,900 shares of IONS stock, worth $1.12 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
32,900
Previous 34,600 4.91%
Holding current value
$1.12 Million
Previous $1.42 Million 5.14%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Jan 02, 2024

SELL
$38.5 - $47.13 $65,450 - $80,121
-1,700 Reduced 4.91%
32,900 $1.49 Million
Q2 2023

Aug 22, 2023

BUY
$34.73 - $43.33 $406,340 - $506,961
11,700 Added 51.09%
34,600 $1.42 Million
Q1 2023

Jul 11, 2023

SELL
$33.58 - $41.2 $265,282 - $325,480
-7,900 Reduced 25.65%
22,900 $818,000
Q4 2022

May 17, 2023

BUY
$37.12 - $46.52 $155,904 - $195,384
4,200 Added 15.79%
30,800 $1.16 Billion
Q3 2022

May 16, 2023

BUY
$36.54 - $48.66 $971,964 - $1.29 Million
26,600 New
26,600 $1.18 Billion
Q1 2022

Apr 21, 2022

SELL
$29.88 - $37.04 $215,136 - $266,688
-7,200 Closed
0 $0
Q4 2021

Feb 03, 2022

SELL
$25.61 - $35.1 $115,245 - $157,950
-4,500 Reduced 38.46%
7,200 $219,000
Q3 2021

Oct 21, 2021

BUY
$33.54 - $40.55 $392,418 - $474,434
11,700 New
11,700 $392,000
Q3 2019

Oct 22, 2019

SELL
$59.06 - $72.15 $584,694 - $714,285
-9,900 Closed
0 $0
Q2 2019

Jul 26, 2019

SELL
$62.09 - $86.14 $347,704 - $482,384
-5,600 Reduced 36.13%
9,900 $636,000
Q1 2019

Apr 25, 2019

SELL
$52.92 - $81.17 $412,776 - $633,126
-7,800 Reduced 33.48%
15,500 $1.26 Million
Q4 2018

Feb 07, 2019

BUY
$43.37 - $59.54 $65,054 - $89,310
1,500 Added 6.88%
23,300 $1.26 Million
Q2 2018

Aug 03, 2018

BUY
$40.53 - $50.7 $883,554 - $1.11 Million
21,800 New
21,800 $908,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $4.82B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.